22057 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Hudis
    Hudis
  4. Kris
    Kris
  5. Saltz
    Saltz
  6. Offit
    Offit
  7. O'Reilly
    O'Reilly
  8. Solit
    Solit
  9. Robson
    Robson
  10. Drilon
    Drilon

Groups

  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)
  7. Breast Medicine Service (4103)
  8. Surgery (4019)
  9. Department of Pathology and Laboratory Medicine (3422)
  10. Thoracic Oncology (3351)
  1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Continued use of afatinib with the addition of cetuximab after progression on afatinib in patients with EGFR mutation-positive non-small-cell lung cancer and acquired resistance to gefitinib or erlotinib
    Journal Article

    Horn, L.; Gettinger, S.; Camidge, D. R.; Smit, E. F.; Janjigian, Y. Y.; Miller, V. A.; Pao, W.; Freiwald, M.; Fan, J.; Wang, B.; more...
    Lung Cancer (2017)

    Fulltext@MSK | Save
  • Alveolar soft part sarcoma of the bladder with ASPSCR1-TFE3 gene fusion as a secondary malignancy
    Journal Article

    Rhee, D. S.; Dunkel, I. J.; Shukla, N. N.; Walsh, M. F.; Gilheeney, S. W.; Price, A. P.; Antonescu, C. R.; Heaton, T. E.
    Journal of Pediatric Surgery Case Reports (2017)

    Fulltext@MSK | Save
  • BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology
    Journal Article

    Chiang, S.; Lee, C. H.; Stewart, C. J. R.; Oliva, E.; Hoang, L. N.; Ali, R. H.; Hensley, M. L.; Arias-Stella, J. A. 3rd; Frosina, D.; Jungbluth, A. A.; more...
    Modern Pathology (2017)

    Fulltext@MSK | Save
  • (89)Zr-DFO-AMG102 immuno-PET to determine local hepatocyte growth factor protein levels in tumors for enhanced patient selection
    Journal Article

    Price, E. W.; Carnazza, K. E.; Carlin, S. D.; Cho, A.; Edwards, K. J.; Sevak, K. K.; Glaser, J. M.; de Stanchina, E.; Janjigian, Y. Y.; Lewis, J. S.
    Journal of Nuclear Medicine (2017)

    Fulltext@MSK | Save
  • Adjuvant systemic therapy and adjuvant radiation therapy for stage I to IIIA completely resected non-small-cell lung cancers: American Society of Clinical Oncology/Cancer Care Ontario clinical practice guideline update
    Journal Article

    Kris, M. G.; Gaspar, L. E.; Chaft, J. E.; Kennedy, E. B.; Azzoli, C. G.; Ellis, P. M.; Lin, S. H.; Pass, H. I.; Seth, R.; Shepherd, F. A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase II trial of atezolizumab as first-line or subsequent therapy for patients with programmed death-ligand 1-selected advanced non-small-cell lung cancer (BIRCH)
    Journal Article

    Peters, S.; Gettinger, S.; Johnson, M. L.; Jänne, P. A.; Garassino, M. C.; Christoph, D.; Toh, C. K.; Rizvi, N. A.; Chaft, J. E.; Costa, E. C.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Quantitative assessment of early [(18)F]sodium fluoride positron emission tomography/computed tomography response to treatment in men with metastatic prostate cancer to bone
    Journal Article

    Harmon, S. A.; Perk, T.; Lin, C.; Eickhoff, J.; Choyke, P. L.; Dahut, W. L.; Apolo, A. B.; Humm, J. L.; Larson, S. M.; Morris, M. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Reply to M. Nishino et al
    Journal Article

    Naidoo, J.; Iyriboz, T.; Cunningham, J.; Hellmann, M. D.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Anthracyclines in early breast cancer: The ABC trials - USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology)
    Journal Article

    Blum, J. L.; Flynn, P. J.; Yothers, G.; Asmar, L.; Geyer, C. E., Jr.; Jacobs, S. A.; Robert, N. J.; Hopkins, J. O.; O’Shaughnessy, J. A.; Dang, C. T.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing
    Journal Article

    Mandelker, D.; Zhang, L.; Kemel, Y.; Stadler, Z. K.; Joseph, V.; Zehir, A.; Pradhan, N.; Arnold, A.; Walsh, M. F.; Li, Y.; more...
    JAMA - Journal of the American Medical Association (2017)

    Fulltext@MSK | Save